NCT06523465View on ClinicalTrials.gov

Statin Combined with Amlodipine Treats Primary Aldosteronism

PHASE4RecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

September 10, 2024

Primary Completion Date

December 30, 2025

Study Completion Date

September 30, 2026

Conditions
Primary AldosteronismStatinMineralocorticoid Receptor AntagonistHypertension
Interventions
DRUG

Simvastatin combined with Amlodipine besylate

6-month treatment of Simvastatin combined with Amlodipine besylate

DRUG

Simvastatin combined with Spironolactone and Amlodipine besylate.

6-month treatment of Simvastatin combined with Spironolactone and Amlodipine besylate.

DRUG

Amlodipine besylate combined Spironolactone

6-month treatment of Amlodipine besylate combined with Spironolactone

Trial Locations (1)

400042

RECRUITING

No. 10 Changjiang River Branch, Yuzhong District，Chongqing, China, Chongqing

All Listed Sponsors
lead

Third Military Medical University

OTHER